Referências

1. Abikoff, H., Hechtman, L., Klein, R.G., Gallagher, R., Fleiss, K., Etcovitch, J., Pollack, S., Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment (2004) Journal of the American Academy of Child and Adolescent Psychiatry, 43, pp. 820-829
2. Abikoff, H., Hechtman, L., Klein, R.G., Weiss, G., Fleiss, K., Etcovitch, J., Pollack, S., Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment (2004) Journal of the American Academy of Child and Adolescent Psychiatry, 43, pp. 802-811
3. ADHD: Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents (2011) Pediatrics, 128, pp. 1007-1022
4. (1994) Diagnostic and Statistical Manual of Mental Disorders, , (4th ed.). Washington, DC: American Psychiatric Press
5. Antshel, K.M., Barkley, R., Psychosocial interventions in attention deficit hyperactivity disorder (2008) Child and Adolescent Psychiatric Clinics of North America, 17, pp. 421-437
6. Barkley, R.A., Cox, D., A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance (2007) Journal of Safety Research, 38, pp. 113-128
7. Barkley, R.A., Fischer, M., The unique contribution of emotional impulsiveness to impairment in major life activities in hyperactive children as adults (2010) Journal of the American Academy of Child and Adolescent Psychiatry, 49, pp. 503-513
8. Bauermeister, J.J., So, C.Y., Jensen, P.S., Krispin, O., El Din, A.S., Development of adaptable and flexible treatment manuals for externalizing and internalizing disorders in children and adolescents (2006) Revista Brasileira de Psiquiatria, 28, pp. 67-71
9. Biederman, J., Melmed, R.D., Patel, A., McBurnett, K., Konow, J., Lyne, A., Scherer, N., A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/ hyperactivity disorder (2008) Pediatrics, 121
10. Bjornstad, G., Montgomery, P., Family therapy for attention-deficit disorder or attention-deficit/hyperactivity disorder in children and adolescents (2005) Cochrane Database of Systematic Reviews, 2, p. CD005042
11. Castells, X., Ramos-Quiroga, J.A., Bosch, R., Nogueira, M., Casas, M., Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults (2011) Cochrane Database of Systematic Reviews, 6, p. CD007813
12. Cheng, J.Y., Chen, R.Y., Ko, J.S., Ng, E.M., Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis (2007) Psychopharmacology, 194, pp. 197-209
13. Cherland, E., Fitzpatrick, R., Psychotic side effects of psychostimulants: A 5-year review (1999) Canadian Journal of Psychiatry, 44, pp. 811-813
14. Clements, S.D., Peters, J.E., Minimal brain dysfunctions in the school-age child. Diagnosis and treatment (1962) Archives of General Psychiatry, 6, pp. 185-197
15. Connor, D.F., Fletcher, K.E., Swanson, J.M., A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder (1999) Journal of the American Academy of Child and Adolescent Psychiatry, 38, pp. 1551-1559
16. Dopfner, M., Psychosocial and other non-pharmacological treatments (2010) ADHD and hyperkinetic disorder, pp. 77-90. , In T. Banaschewski, D. Coghill, M. Danck-aerts, M. Dopfner, L. A. Rohde, J. A. Sergeant, E. J. S. Sonuga-Barke, E. Taylor, & A. Zuddas (Eds.), Oxford: Oxford University Press
17. Dopfner, M., Breuer, D., Schurmann, S., Metternich, T.W., Rademacher, C., Lehmkuhl, G., Effectiveness of an adaptive multimodal treatment in children with attention-deficit hyperactivity disorder-global outcome (2004) European Child & Adolescent Psychiatry, 13 (1), pp. 117-129
18. Elia, J., Vetter, V.L., Cardiovascular effects of medications for the treatment of attention-deficit hyperactivity disorder: What is known and how should it influence prescribing in children? (2010) Paediatric Drugs, 12, pp. 165-175
19. Fabiano, G.A., Pelham, W.E., Jr., Coles, E.K., Gnagy, E.M., Chronis-Tuscano, A., O'Connor, B.C., A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder (2009) Clinical Psychology Review, 29, pp. 129-140
20. Faraone, S.V., Using meta-analysis to compare the efficacy of medications for attention-deficit/hyperactivity disorder in youths (2009) P & T: A Peer-Reviewed Journal for Formulary Management, 34, pp. 678-694
21. Faraone, S.V., Biederman, J., Efficacy of Adderall for attention-deficit/hyperactivity disorder: A meta-analysis (2002) Journal of Attention Disorders, 6, pp. 69-75
22. Faraone, S.V., Biederman, J., Mick, E., The age-dependent decline of attention deficit hyperactivity disorder: A meta-analysis of follow-up studies (2006) Psychological Medicine, 36, pp. 159-165
23. Faraone, S.V., Biederman, J., Morley, C.P., Spencer, T.J., Effect of stimulants on height and weight: A review of the literature (2008) Journal of the American Academy of Child and Adolescent Psychiatry, 47, pp. 994-1009
24. Faraone, S.V., Biederman, J., Roe, C., Comparative efficacy of Adderall and methylphenidate in attention-deficit/ hyperactivity disorder: A meta-analysis (2002) Journal of Clinical Psychopharmacology, 22, pp. 468-473
25. Faraone, S.V., Biederman, J., Spencer, T.J., Aleardi, M., Comparing the efficacy of medications for ADHD using meta-analysis (2006) Medscape General Medicine, 8, p. 4
26. Faraone, S.V., Buitelaar, J., Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis (2010) European Child & Adolescent Psychiatry, 19, pp. 353-364
27. Geller, D., Donnelly, C., Lopez, F., Rubin, R., Newcorn, J., Sutton, V., Sumner, C., Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder (2007) Journal of the American Academy of Child and Adolescent Psychiatry, 46, pp. 1119-1127
28. Hanwella, R., Senanayake, M., de Silva, V., Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: A meta-analysis (2011) BMC Psychiatry, 11, p. 176
29. Hazell, P.L., Kohn, M.R., Dickson, R., Walton, R.J., Granger, R.E., Wyk, G.W., Core ADHD symptom improvement with atomoxetine versus methylphenidate: A direct comparison meta-analysis (2011) Journal of Attention Disorders, 15, pp. 674-683
30. Jain, R., Segal, S., Kollins, S.H., Khayrallah, M., Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder (2011) Journal of the American Academy of Child and Adolescent Psychiatry, 50, pp. 171-179
31. Kattimani, S., Mahadevan, S., Treating children with attention-deficit/hyperactivity disorder and comorbid epilepsy (2011) Annals of Indian Academy of Neurology, 14, pp. 9-11
32. Klassen, A., Miller, A., Raina, P., Lee, S.K., Olsen, L., Attention-deficit hyperactivity disorder in children and youth: A quantitative systematic review of the efficacy of different management strategies (1999) Canadian Journal of Psychiatry, 44, pp. 1007-1016
33. Kollins, S.H., Jain, R., Brams, M., Segal, S., Findling, R.L., Wigal, S.B., Khayrallah, M., Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD (2011) Pediatrics, 127
34. Kratochvil, C.J., Wilens, T.E., Greenhill, L.L., Gao, H., Baker, K.D., Feldman, P.D., Gelowitz, D.L., Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder (2006) Journal of the American Academy of Child and Adolescent Psychiatry, 45, pp. 919-927
35. Lawson, K.A., Johnsrud, M., Hodgkins, P., Sasane, R., Crismon, M.L., Utilization patterns of stimulants in ADHD in the Medicaid population: A retrospective analysis of data from the Texas Medicaid program (2012) Clinical Therapeutics, 34, pp. 944-956
36. Majewicz-Hefley, A., Carlson, J.S., A meta-analysis of combined treatments for children diagnosed with ADHD (2007) Journal of Attention Disorders, 10, pp. 239-250
37. Mannuzza, S., Klein, R.G., Bessler, A., Malloy, P., Hynes, M.E., Educational and occupational outcome of hyperactive boys grown up (1997) Journal of the American Academy of Child and Adolescent Psychiatry, 36, pp. 1222-1227
38. Mannuzza, S., Klein, R.G., Bessler, A., Malloy, P., LaPadula, M., Adult psychiatric status of hyperactive boys grown up (1998) American Journal of Psychiatry, 155, pp. 493-498
39. Marcus, S.C., Wan, G.J., Kemner, J.E., Olfson, M., Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder (2005) Archives of Pediatrics & Adolescent Medicine, 159, pp. 572-578
40. Molina, B.S., Hinshaw, S.P., Swanson, J.M., Arnold, L.E., Vitiello, B., Jensen, P.S., The MTA at 8 years: Prospective follow-up of children treated for combined-type ADHD in a multisite study (2009) Journal of the American Academy of Child and Adolescent Psychiatry, 48 (5), pp. 484-500
41. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD (1999) Archives of General Psychiatry, 56, pp. 1073-1086
42. Nair, V., Mahadevan, S., Randomised controlled study-efficacy of clonidine versus carbamazepine in children with ADHD (2009) Journal of Tropical Pediatrics, 55, pp. 116-121
43. (2008) Attention deficit hyperactivity disorder diagnosis and management of ADHD in children, young people and adults, , http://www.nice.org.uk/nicemedia/live/12061/42059/42059.pdf
44. Palli, S.R., Kamble, P.S., Chen, H., Aparasu, R.R., Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder (2012) Journal of Child and Adolescent Psychopharmacology, 22, pp. 139-148
45. Peterson, K., McDonagh, M.S., Fu, R., Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: A systematic review and indirect comparison meta-analysis (2008) Psycho-pharmacology, 197, pp. 1-11
46. Pliszka, S., Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/ hyperactivity disorder (2007) Journal of the American Academy of Child and Adolescent Psychiatry, 46, pp. 894-921
47. Polanczyk, G., de Lima, M.S., Horta, B.L., Biederman, J., Rohde, L.A., The worldwide prevalence of ADHD: A systematic review and metaregression analysis (2007) American Journal of Psychiatry, 164, pp. 942-948
48. Remschmidt, H., Global consensus on ADHD/HKD (2005) European Child & Adolescent Psychiatry, 14, pp. 127-137
49. Ross, R.G., Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder (2006) The American Journal of Psychiatry, 163, pp. 1149-1152
50. Sallee, F.R., McGough, J., Wigal, T., Donahue, J., Lyne, A., Biederman, J., Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: A placebo-controlled trial (2009) Journal of the American Academy of Child and Adolescent Psychiatry, 48, pp. 155-165
51. Schachter, H.M., Pham, B., King, J., Langford, S., Moher, D., How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis (2001) Canadian Medical Association Journal, 165, pp. 1475-1488
52. Spencer, T., Biederman, J., Wilens, T., Harding, M., O'Donnell, D., Griffin, S., Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle (1996) Journal of the American Academy of Child and Adolescent Psychiatry, 35, pp. 409-432
53. Stein, M.A., Impairment associated with adult ADHD (2008) CNS Spectrums, 13 (8), pp. 9-11
54. Stiefel, G., Besag, F.M., Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder (2010) Drug Safety, 33, pp. 821-842
55. Storebo, O.J., Skoog, M., Damm, D., Thomsen, P.H., Simonsen, E., Gluud, C., Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years (2011) Cochrane Database of Systematic Reviews, 12, p. CD008223
56. Taylor, E., Dopfner, M., Sergeant, J., Asherson, P., Banaschewski, T., Buitelaar, J., Zuddas, A., European clinical guidelines for hyperkinetic disorder-first upgrade (2004) European Child & Adolescent Psychiatry, 13 (1), pp. 17-30
57. van der Oord, S., Prins, P.J., Oosterlaan, J., Emmelkamp, P.M., Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: A meta-analysis (2008) Clinical Psychology Review, 28, pp. 783-800
58. Winterstein, A.G., Gerhard, T., Shuster, J., Zito, J., Johnson, M., Liu, H., Saidi, A., Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database (2008) Annals of Pharmacotherapy, 42, pp. 24-31
59. (1993) The ICD-10 classification of mental and behavioral disorders: Diagnostic criteria for research, , Geneva: Author
60. Zwi, M., Jones, H., Thorgaard, C., York, A., Dennis, J.A., Parent training interventions for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years (2011) Cochrane Database of Systematic Reviews, 12, p. CD003018